Back to Search
Start Over
EBV-positive lymphoproliferative disease with medullary, splenic and hepatic infiltration after imatinib mesylate therapy for chronic myeloid leukemia.
- Source :
-
Leukemia [Leukemia] 2007 Oct; Vol. 21 (10), pp. 2208-10. Date of Electronic Publication: 2007 May 31. - Publication Year :
- 2007
- Subjects :
- Antineoplastic Agents adverse effects
Benzamides
Cell Proliferation
Female
Humans
Imatinib Mesylate
In Situ Hybridization, Fluorescence
Lymphoproliferative Disorders chemically induced
Lymphoproliferative Disorders metabolism
Middle Aged
Recurrence
Translocation, Genetic
Herpesvirus 4, Human metabolism
Kidney Medulla virology
Leukemia, Myelogenous, Chronic, BCR-ABL Positive drug therapy
Leukemia, Myelogenous, Chronic, BCR-ABL Positive pathology
Liver virology
Lymphoproliferative Disorders virology
Piperazines adverse effects
Pyrimidines adverse effects
Spleen virology
Subjects
Details
- Language :
- English
- ISSN :
- 0887-6924
- Volume :
- 21
- Issue :
- 10
- Database :
- MEDLINE
- Journal :
- Leukemia
- Publication Type :
- Report
- Accession number :
- 17541400
- Full Text :
- https://doi.org/10.1038/sj.leu.2404758